We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+0.42%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.12B
AUM Growth
+$762M
(+14%)
Cap. Flow
+$908M
Cap. Flow
% of AUM
14.82%
Top 10 Holdings %
Top 10 Hldgs %
15.76%
Holding
794
New
208
Increased
110
Reduced
107
Closed
121
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$85M |
| 2 |
Abbott
ABT
|
+$72M |
| 3 |
NVIDIA
NVDA
|
+$60.9M |
| 4 |
Teradyne
TER
|
+$52.2M |
| 5 |
Legend Biotech
LEGN
|
+$50.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amphenol
APH
|
+$98.7M |
| 2 |
Texas Instruments
TXN
|
+$95.4M |
| 3 |
Global Payments
GPN
|
+$54.3M |
| 4 |
Johnson & Johnson
JNJ
|
+$49.4M |
| 5 |
KLA
KLAC
|
+$49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.26% |
| 2 | Technology | 25.67% |
| 3 | Communication Services | 8.98% |
| 4 | Financials | 5.47% |
| 5 | Consumer Staples | 3.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Teradyne
TER
$54.8B
| $132M | 2.15% |
1,206,563
+429,215
| +55% | +$52.2M |
|
|
2
Johnson & Johnson
JNJ
$634B
| $123M | 2.01% |
763,232
-289,670
| -28% | -$49.4M |
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $119M | 1.94% |
1,084,213
+4
| +0% | +$415 |
|
4
Alphabet (Google) Class A
GOOGL
$3.91T
| $104M | 1.7% |
777,180
+352,440
| +83% | +$48M |
|
|
SGEN
5
DELISTED
Seagen Inc. Common Stock
SGEN
| $98.1M | 1.6% |
577,704
+49
| +0% | +$7.63K |
|
6
AbbVie
ABBV
$458B
| $84.2M | 1.37% |
780,409
+169,879
| +28% | +$19.4M |
|
7
Electronic Arts
EA
$52.4B
| $77.6M | 1.27% |
545,301
-56,229
| -9% | -$7.89M |
|
|
8
Qualcomm
QCOM
$176B
| $77.3M | 1.26% |
+599,018
| New | +$85M |
|
9
Gilead Sciences
GILD
$161B
| $75.5M | 1.23% |
1,080,167
| – | – |
|
|
10
Legend Biotech
LEGN
$4.3B
| $74.8M | 1.22% |
1,478,594
+1,205,551
| +442% | +$50.2M |
|
11
Eli Lilly
LLY
$1.07T
| $73M | 1.19% |
316,103
+158,412
| +100% | +$39.1M |
|
|
12
KLA
KLAC
$275B
| $69.9M | 1.14% |
2,090,470
-1,468,310
| -41% | -$49M |
|
|
13
Abbott
ABT
$180B
| $69.2M | 1.13% |
+586,038
| New | +$72M |
|
14
Booking.com
BKNG
$138B
| $67.7M | 1.11% |
713,175
-14,100
| -2% | -$1.27M |
|
15
Cooper Companies
COO
$13.7B
| $63.2M | 1.03% |
611,380
+15,944
| +3% | +$1.7M |
|
16
PagSeguro Digital
PAGS
$2.57B
| $60.9M | 0.99% |
1,177,550
+273,346
| +30% | +$15.3M |
|
|
17
NVIDIA
NVDA
$5.01T
| $60.7M | 0.99% |
+2,931,150
| New | +$60.9M |
|
18
Neurocrine Biosciences
NBIX
$17.7B
| $60.4M | 0.99% |
629,837
+244,783
| +64% | +$23.1M |
|
19
Vishay Intertechnology
VSH
$5.86B
| $60.1M | 0.98% |
2,989,302
-55,751
| -2% | -$1.21M |
|
20
Arcus Biosciences
RCUS
$3.57B
| $59.2M | 0.97% |
1,699,113
+35,545
| +2% | +$1.11M |
|
21
Thomson Reuters
TRI
$39.4B
| $53.7M | 0.88% |
461,178
-18,754
| -4% | -$2.19M |
|
22
Danaher
DHR
$135B
| $52.7M | 0.86% |
195,314
+44,969
| +30% | +$12.2M |
|
23
Pfizer
PFE
$140B
| $51.4M | 0.84% |
1,195,070
+610,969
| +105% | +$27.1M |
|
|
NATI
24
DELISTED
National Instruments Corp
NATI
| $47.7M | 0.78% |
1,216,670
+290,185
| +31% | +$12.1M |
|
25
Viavi Solutions
VIAV
$9.75B
| $47.4M | 0.77% |
3,013,228
+2,121,551
| +238% | +$34.8M |
|
Similar funds
KAS
PAM
TCIIS
Woodline Partners's Q3 2021 Portfolio in Review
As of Q3 2021, Woodline Partners held 794 positions worth $6.12B, up 14% from $5.36B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Woodline Partners deployed $908M of net new capital in Q3 2021, opening 208 new positions and adding to 110 existing holdings. Its largest new stake was Qualcomm: 599,018 shares worth $77.3M.
By sector, the portfolio is most concentrated in Healthcare at 46% of assets, down from 47% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Amphenol, an estimated $98.7M trimmed.
- Woodline Partners's largest Q3 2021 buy was Qualcomm: 599,018 shares worth $77.3M.
- Woodline Partners added most to Teradyne in Q3 2021, an estimated $52.2M increase.
- Woodline Partners's biggest Q3 2021 reduction was Amphenol, cutting an estimated $98.7M.
- Woodline Partners fully exited Boston Scientific in Q3 2021, selling an estimated $44.9M.
- Woodline Partners's ten largest holdings make up 16% of its $6.12B portfolio in Q3 2021.
- Woodline Partners opened 208 new positions and closed 121 in Q3 2021.
- Woodline Partners's portfolio value rose 14% quarter-over-quarter to $6.12B.
Based on Woodline Partners's 13F filing for Q3 2021, filed 15 Nov 2021.